This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Will Bed Bath & Beyond (BBBY) Disappoint in Q3 Earnings?
by Zacks Equity Research
Bed Bath & Beyond Inc. (BBBY) is slated to release third-quarter fiscal 2017 results on Dec 20. The company has been lately grappling with soft traffic trends and weak margins.
Cardinal Health Banks on Buyouts Amid Intense Competition
by Zacks Equity Research
Cardinal Health (CAH) consistently works on launching products and carrying out acquisitions to boost revenues.
Bear of the Day: Revlon (REV)
by Madeleine Johnson
This cosmetics giant may not be the best beauty fix for your portfolio right now.
AmerisourceBergen (ABC) Beats Q4 Earnings, Issues FY18 View
by Zacks Equity Research
Solid growth in the Pharmaceutical Distribution Services segment drove AmerisourceBergen's (ABC) top line in the fourth quarter.
Bear of the Day: GNC Holdings (GNC)
by Ryan McQueeney
The decline of brick-and-mortar stores has been well-documented, but this specialty retailer has problems all its own.
Top Research Reports for JPMorgan Chase, Gilead & ConocoPhillips
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase (JPM), Gilead (GILD) and ConocoPhillips (COP).
Astounding Earnings Overall
by Zacks Equity Research
Astounding Earnings Overall
Walgreens Boots (WBA) Tops Q4 Earnings, Revenues Estimates
by Zacks Equity Research
Walgreens Boots (WBA) rides high in Q4 on strength in Retail Pharmacy USA division and Pharmaceutical Wholesale division.
Rite Aid Stock Down 80% This Year: Is Amazon the Only Threat?
by Zacks Equity Research
Amazon's expansion strategy is not the only reason behind Rite Aid's (RAD) debacle. Let's take a look at the other reasons for which this stock has lost ground.
Top Analyst Reports for Citigroup, 3M & Walgreens Boots
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Citigroup (C), 3M (MMM) and Walgreens Boots (WBA).
Why Did Rite Aid (RAD) Stock Crash Today?
by Ryan McQueeney
Shares of Rite Aid (RAD) fell more than 10% on Tuesday after Walgreens Boots (WBA) received government approval to buy fewer Rite Aid stores than had initially been proposed.
Should Value Investors Consider Walgreens Boots (WBA) Stock?
by Zacks Equity Research
Is Walgreens Boots (WBA) a great pick from the value investor's perspective right now? Read on to know more.
Tobacco Stocks in Focus as Cigarette Prices Rise in New York
by Zacks Equity Research
The news of cigarette price hike in New York City and other legislations to reduce the number of smokers have raised concerns of accelerated sales declines for traditional cigarettes.
Why Is Walgreens Boots (WBA) Down 4.4% Since the Last Earnings Report?
by Zacks Equity Research
Walgreens Boots (WBA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Walgreens, Rite Aid Ditch Long-Suffering Drugstore Merger
by Madeleine Johnson
On Thursday, Walgreens Boots Alliance (WBA) announced that it has abandoned efforts to merge with fellow drugstore chain Rite Aid (RAD). Instead, Walgreens will purchase almost half if its rivals stores in a new deal.
Walgreens Boots (WBA) Tops Q3 Earnings, Revenues Estimates
by Zacks Equity Research
Currently, Walgreens Boots has a Zacks Rank #3 (Hold) but that could change following its impressive third quarter fiscal 2017 earnings report which has just released.
Top Analyst Reports for Amazon, Visa, Verizon & Citigroup
by Mark Vickery
Today's Research Daily features new research reports on 17 major stocks, including Amazon (AMZN), Visa (V), Verizon (VZ) and Citigroup (C).
Is Walgreens (WBA) a Great Stock for Value Investors?
by Zacks Equity Research
Value investing is easily one of the most popular ways to find great stocks in any market environment.
Could Amazon Be the Next Big Pharmacy Giant?
by Madeleine Johnson
Amazon is reportedly looking to expand into new territory. According to CNBC, the e-commerce giant is trying to figure out how it can break into the multi-billion-dollar pharmacy industry.
Walgreens Boots (WBA) Up 5.4% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Walgreens Boots (WBA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Research Reports for Today: AMZN, CELG, FB, WBA
by Mark Vickery
Today's Research Daily features new research reports on 17 major stocks, including Amazon (AMZN), Celgene (CELG), Facebook (FB) and Walgreens Boots (WBA).
Company News for April 06, 2017
by Zacks Equity Research
Companies in the News are: PNRA,SPLS,MON,WBA
Walgreens Boots (WBA) Meets Q2 Earnings, Misses on Revenues
by Zacks Equity Research
Currently, Walgreens Boots has a Zacks Rank #3 (Hold) but that could change following its dull second quarter fiscal 2017 earnings report which has just released.
Earnings Season in Focus
by Zacks Equity Research
Earnings Season in Focus
Plenty to Look Forward To
by Mark Vickery
We are anticipating another strong quarter of growth as Q1 earnings season starts in the next couple weeks.